# ROCKET PHARMACEUTICALS INC (RCKT)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/RCKT/

- Reporting holders: 2
- Reported value: $9.6K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $6.0K | 2,277 | 0.0% | 13 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $3.6K | 1,359 | 0.0% | 4 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 2 | $9.6K |
| Q2 2026 | 180 | $352.4M |
| Q1 2026 | 197 | $350.0M |
| Q4 2025 | 183 | $323.0M |
| Q3 2025 | 173 | $325.2M |
| Q2 2025 | 196 | $238.4M |
| Q1 2025 | 238 | $728.9M |
| Q4 2024 | 224 | $1.4B |
| Q3 2024 | 191 | $1.7B |
| Q2 2024 | 180 | $2.0B |
| Q1 2024 | 190 | $2.5B |
| Q4 2023 | 196 | $2.7B |